The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies.
about
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease miceMultiple Targeting Approaches on Histamine H3 Receptor AntagonistsThe power of using functional fMRI on small rodents to study brain pharmacology and diseaseDistribution and effects of the muscarinic receptor subtypes in the primary visual cortexImportant poisonous plants in tibetan ethnomedicineFermented Sipjeondaebo-tang Alleviates Memory Deficits and Loss of Hippocampal Neurogenesis in Scopolamine-induced Amnesia in Mice.Toxin-Induced Experimental Models of Learning and Memory ImpairmentDrug models of schizophreniaAVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in miceA comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairmentEffects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivorsBlockade of muscarinic receptors impairs the retrieval of well-trained memory.Scopolamine provocation-based pharmacological MRI model for testing procognitive agents.Low-dose systemic scopolamine disrupts context conditioning in ratsBerberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities.EEG machine learning for accurate detection of cholinergic intervention and Alzheimer's disease.Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats.Amnesia of inhibitory avoidance by scopolamine is overcome by previous open-field exposure.Complete chloroplast genome sequence of poisonous and medicinal plant Datura stramonium: organizations and implications for genetic engineering.The potent effects of ginseng root extract and memantine on cognitive dysfunction in male albino rats.Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognition.Basal forebrain activation controls contrast sensitivity in primary visual cortex.D-cycloserine in prelimbic cortex reverses scopolamine-induced deficits in olfactory memory in rats.Post-training scopolamine treatment induced maladaptive behavior in open field habituation task in rats.Hippocampal M1 receptor function associated with spatial learning and memory in aged female rhesus macaques.The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice.Cholinergic modulation of working memory activity in primate prefrontal cortex.Selective inhibition of striatal fast-spiking interneurons causes dyskinesiasA Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulationEmilia coccinae (SIMS) G Extract improves memory impairment, cholinergic dysfunction, and oxidative stress damage in scopolamine-treated rats.A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 MiceBacopa monniera (CDRI-08) Upregulates the Expression of Neuronal and Glial Plasticity Markers in the Brain of Scopolamine Induced Amnesic Mice.Intraperitoneal Administration of a Novel TAT-BDNF Peptide Ameliorates Cognitive Impairments via Modulating Multiple Pathways in Two Alzheimer's Rodent Models.Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.Performance of conventional pigs and Göttingen miniature pigs in a spatial holeboard task: effects of the putative muscarinic cognition impairer Biperiden.Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition TasksThe role of glutamatergic pathway between septum and hippocampus in the memory formation.The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.Long-term trihexyphenidyl exposure alters neuroimmune response and inflammation in aging rat: relevance to age and Alzheimer's disease
P2860
Q21195685-1DC46ED3-4F69-42AD-909B-6BDE13040796Q26746056-286ED09E-F281-41EE-91FA-FF9C1CE5D20BQ26779671-EBD59B5B-DB1D-47CB-A32B-E1F7F0FC6D6CQ26851426-E8768587-48E8-41FA-A32F-350EADE7FBD0Q26998433-CF56F7AC-E6CF-4870-B5B0-9A124100EFABQ27335037-51E2128C-C611-4CBF-856F-E0935171E723Q28075913-A18B1EE6-C0FA-4A19-A625-CC51D40E04F1Q28084198-7C1C80FA-B6EA-458C-B152-646349384144Q30377178-3E086576-2715-45CF-9134-981F45E37F18Q30446313-EA03707F-49F3-4608-9326-A1D7381AAE36Q30475205-3E504501-CFF7-4AC0-9854-7623A7E04E74Q30540341-C330AA71-77A1-4C48-8544-4CAD1549DF36Q30576082-C5C7C596-6621-401D-A723-FD96C3A0AEEAQ30884365-91544BB2-A74E-4B0D-94FC-B491408E492EQ33772516-3A5A6DD9-02A2-4A2D-B64E-611C7DC172D0Q33819605-CB2B59DA-862F-4FF4-99C2-F6E4E756774DQ33915806-7F955BDD-5D85-4200-AB59-2376BB1FB7ABQ34268232-2DD50DDE-1B43-480D-8EE7-340F0C7CF867Q34363811-6C069612-1878-4281-A2D7-CE2F5C20F8A3Q34443826-C8CFA2A2-4E4C-4F35-9FCB-8BE84DDE17D4Q34648231-39FC2CCE-11B7-4BD4-BE8E-4C5F4BE73613Q34702234-B32CC960-B1A4-48C3-8468-51B2E37571F2Q34725679-3638D2E9-B6C6-4359-8A58-0177D983DA87Q34926000-4E9D2FB4-E51E-48C7-B72C-C25ABE21A610Q35189502-7CA376AE-70AE-4A1C-80B8-F2A16B02C0EFQ35201147-C6AB85DF-D7DC-4DF3-8F05-5FBC60662111Q35538511-D2C23E84-DB3E-44C5-8125-4DAC9B6FE951Q35543969-69387F67-7A91-4439-8D29-C02766E8635BQ35580745-6D601DC2-2095-4578-A738-A300FBAFDE66Q35643821-26F71A78-8F97-4495-A165-FA7060CE75BBQ35786061-EA04BE99-34A9-49EA-9EFE-DB395E0181E7Q35903525-81C99DD8-727C-48EC-B104-24E02BDAF2E0Q36043628-17FC3CD8-95A6-42A2-93AB-9097FC0EF4E6Q36158803-4F735FAD-ED45-4AB8-A80D-B562D2F88350Q36486037-703390CC-3DE8-40D5-8F40-72E2FD04C121Q36585301-76541C39-0573-442E-B3ED-27B7C0B32ABBQ36687431-BDC6270E-ABB2-49B5-B8DE-83A48878E896Q36920687-456B8208-722F-4C85-833E-F79EF981BAF1Q37037197-012CAD77-39A5-4D02-8143-2ED44D3AB311Q37089887-A89F02DC-99EA-4497-9397-2DA9CECDDD5C
P2860
The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The validity of scopolamine as ...... of animal behavioral studies.
@en
The validity of scopolamine as ...... of animal behavioral studies.
@nl
type
label
The validity of scopolamine as ...... of animal behavioral studies.
@en
The validity of scopolamine as ...... of animal behavioral studies.
@nl
prefLabel
The validity of scopolamine as ...... of animal behavioral studies.
@en
The validity of scopolamine as ...... of animal behavioral studies.
@nl
P1476
The validity of scopolamine as ...... of animal behavioral studies.
@en
P2093
Arjan Blokland
Inge Klinkenberg
P304
P356
10.1016/J.NEUBIOREV.2010.04.001
P577
2010-04-14T00:00:00Z